11 | less than a week out from launch! any predictions | Bent2Break | 07/25/2017 2:01:54 PM |
10 | nice moves +29% doesn't take much volume to get | Bent2Break | 07/11/2017 12:31:26 PM |
9 | HRRN Financials 07/16/2014 19:16:15 HE-5 | Emylers | 07/16/2014 8:16:10 PM |
8 | HRRN 0.0002 Stock Charts $HRRN 1 Month Chart | chartguy89 | 03/07/2014 7:08:50 PM |
7 | HRRN Stock Charts Last: UNCH Wednesday, February | chartguy89 | 02/26/2014 9:58:49 PM |
6 | MY PLAYS LAST 5-7+ DAYS...HRRN IS GOING INTO DAY | stockfalcon | 02/19/2013 6:46:10 AM |
5 | HRRN .0009 im telling you all we are going to | stockfalcon | 02/19/2013 6:45:32 AM |
4 | Many groups joining in on tuesday...alerted at | stockfalcon | 02/18/2013 6:27:37 PM |
3 | The reason why it moved from .0002 to .0009 so | stockfalcon | 02/18/2013 6:25:58 PM |
2 | Check the chart back in oct last year....took | stockfalcon | 02/18/2013 6:25:19 PM |
1 | HRRN .0009 Maxed AS/OS play...my favorite | stockfalcon | 02/18/2013 6:24:01 PM |
Recent Articles
- Introducing 247Tasker: Revolutionizing Freelancing Globally
- Urgent Investor Alert: Centene Corporation Class Action Insights
- Dimassi's Mediterranean Buffet Expands to New Location in Texas
- COLMO's EVOLUTION 2.0 Series Transforms Luxury Home Living
- COLMO EVOLUTION 2.0: A Gold Standard in Home Innovation
- Empowering Teenagers Through Success-in-You Program Launch
- Air Canada and CUPE Enter Mediation Amid Wage Negotiations
- RugOne Launches Innovative Rugged Smartphone at IFA 2025
- GlocalMe Unveils Innovative Solutions at Major Tech Expo
- Investors Have a Unique Opportunity for Recovery with CTO Realty
- Picasso Print DTF Increases Production by 130% with AI Technology
- Rosen Law Firm Investigates Disney for Children's Privacy Concerns
- Understanding Unclaimed Lottery Winnings: Powerball Insights
- TCL Achieves Milestone in Mini LED Market Share Growth
- GlocalMe Unveils Innovative Connectivity Solutions at IFA 2025
- John Monsky's Impactful Multisensory Performance for Kids
- Investors Urged to Lead Class Action Against Altimmune, Inc.
- Critical Guidance for Fiserv, Inc. Investors Facing Losses
- Encaleret Demonstrates Exciting Results for Calcium Normalization
- Federal Court Upholds Immigration Protections for TPS Holders
- Harnessing Executive Function Coaching for Long-Term Success
- CIGA Design's Innovative Eco-Friendly Candles at Paris Fair
- Hisense Celebrates Innovation with Nine Awards in 2025
- Justin Sun's Dilemma with World Liberty's Token Freeze
- Hisense Revolutionizes Home Entertainment with Cutting-Edge Tech
- LifeMD Investors: Your Chance to Join the Securities Class Action
- Robinhood's Landmark Inclusion in S&P 500: A New Era for Retail Investing
- Important Update for Nutex Health Investors and Legal Rights
- Faruqi Firm Investigates Fiserv Investors Ahead of Deadline
- Urgent Notice for Semler Scientific Investors on Legal Actions
- TESSAN Enhances Brand Identity with Unique Experience at IFA
- Investors Alert: Investigating Lockheed Martin Claims for Recovery
- Kao Collins Unveils Innovative XBAR Printhead for Businesses
- Insights on Trump Administration's Week 33: Key Developments
- TCL Unveils Innovative Technology at IFA, Celebrates Olympic Spirit
- A Recap of Week 33 under Trump's Leadership and Policies
- BioMarin Shares Exciting New PALYNZIQ Data at Global Metabolism Event
- Revolutionary Display and Sound Technologies from Hisense
- Changhong Unveils Innovative Panda-Inspired Tech at IFA
- Roblox Corporation Faces Legal Scrutiny Amid Allegations
- SuperX AI Faces Scrutiny Amid Allegations of Misrepresentation
- Investors Urged to Act: Replimune Class Action Insight
- Charter Communications Investors: Join the Class Action Today
- Exploring the Digital Health Market: Growth and Innovations Ahead
- Understanding the LifeMD Class Action Lawsuit and What It Means
- Pomerantz Law Firm Investigates Potential Securities Fraud Claims
- Exploring the Growth of the Virtual Production Market by 2030
- Understanding the Securities Investigation of Six Flags Corp
- Novo Nordisk A/S Investors Urged to Act Before Deadline
- Critical Investor Alert: Novo Nordisk Claims Under Review